Your browser doesn't support javascript.
loading
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
Mahomed, Sharana; Garrett, Nigel; Capparelli, Edmund V; Osman, Farzana; Harkoo, Ishana; Yende-Zuma, Nonhlanhla; Gengiah, Tanuja N; Archary, Derseree; Samsunder, Natasha; Baxter, Cheryl; Mkhize, Nonhlanhla N; Modise, Tandile; Carlton, Kevin; McDermott, Adrian; Moore, Penny L; Karim, Quarraisha Abdool; Barouch, Dan H; Fast, Patricia E; Mascola, John R; Ledgerwood, Julie E; Morris, Lynn; Abdool Karim, Salim S.
Afiliación
  • Mahomed S; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Garrett N; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Capparelli EV; Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
  • Osman F; University of California, San Diego, California, USA.
  • Harkoo I; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Yende-Zuma N; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Gengiah TN; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Archary D; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Samsunder N; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Baxter C; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Mkhize NN; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Modise T; National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Carlton K; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • McDermott A; National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Moore PL; Vaccine Research Centre, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Karim QA; Vaccine Research Centre, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Barouch DH; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Fast PE; National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Mascola JR; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Ledgerwood JE; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Morris L; Department of Epidemiology, Columbia University, New York, New York, USA.
  • Abdool Karim SS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
J Infect Dis ; 226(3): 510-520, 2022 08 26.
Article en En | MEDLINE | ID: mdl-35134995

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Estados Unidos